Actuated Medical Private Investor Briefing – San Francisco

Event Details

Actuated Medical Private Investor Briefing - San Francisco

by CONNECTpreneur Investor Network

SUNDAY, January 11, 2026

Please note that this meeting is for DIRECT and ACTIVE investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval.

Opus8 is hosting a small, invitation-only private investor briefing during JP Morgan Week featuring Actuated Medical, a medical device company transforming tools for brain access, biologic therapy delivery, & neural disease treatment.

This closed-door session will provide direct access to the Actuated Medical leadership team and an opportunity to review the company’s neuro platform, clinical direction, and upcoming milestones, as well as its broader strategic roadmap.

Company Overview

Actuated Medical is a med device company transforming tools for brain access, biologic therapy delivery, & neural disease treatment. The company also maintains a portfolio of FDA-cleared technologies, providing strategic and financial optionality as it advances its core neuro program.

What Differentiates Actuated Medical

Large Neurological Opportunity — Platform technology addressing significant unmet needs in neuro procedures
Proprietary Engineering — Differentiated catheter-based design enabling precision access and delivery
Clinical Momentum — Active engagement with leading clinicians and academic medical centers
Strategic Optionality — FDA-cleared assets alongside a focused neuro platform
Experienced Leadership — Proven device development and commercialization expertise

Event Details

Date: Sunday, January 11, 2026
Time: 2 – 3:30 PM PST
Location: Fogo de Chão, San Francisco

Attendance is limited and curated.

Important Notes

Please note that this meeting is for DIRECT and ACTIVE investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval.

To request investor materials, contact:
Skylar Rallison — srallison@opus8.com

Event Details